Production (Stage)
Ovid Therapeutics Inc.
OVID
$0.3186
$0.00531.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 43.00M | 53.08M | 62.71M | 76.97M | 90.26M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.93M | 2.87M | 3.12M | 3.92M | 2.91M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 45.92M | 55.94M | 65.83M | 80.89M | 93.17M |
|
|
|||||
| Total Current Assets | 45.92M | 55.94M | 65.83M | 80.89M | 93.17M |
| Net Property, Plant & Equipment | 12.86M | 13.23M | 13.59M | 13.98M | 14.31M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 38.00K | 92.00K | 155.00K | 219.00K | 148.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.93M | 1.93M | 1.96M | 1.96M | 1.96M |
| Total Assets | 81.65M | 92.17M | 102.65M | 118.09M | 131.61M |
|
|
|||||
| Total Accounts Payable | 1.95M | 3.19M | 2.71M | 4.72M | 3.60M |
| Total Accrued Expenses | 6.00M | 5.99M | 7.61M | 8.11M | 4.04M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.36M | 1.34M | 1.31M | 1.29M | 1.27M |
| Total Finance Division Other Current Liabilities | -- | 1.00K | -- | -- | -- |
| Total Other Current Liabilities | -- | 1.00K | -- | -- | -- |
| Total Current Liabilities | 9.31M | 10.52M | 11.63M | 14.12M | 8.90M |
|
|
|||||
| Total Current Liabilities | 9.31M | 10.52M | 11.63M | 14.12M | 8.90M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 13.07M | 13.42M | 13.76M | 14.10M | 14.43M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.00K | -- | 972.00K | 972.00K | 30.00M |
| Total Liabilities | 22.38M | 23.94M | 26.36M | 29.19M | 53.33M |
|
|
|||||
| Common Stock & APIC | 373.86M | 372.56M | 371.30M | 369.95M | 367.86M |
| Retained Earnings | -314.53M | -304.30M | -295.05M | -281.04M | -289.56M |
| Treasury Stock & Other | -48.00K | -35.00K | 36.00K | -12.00K | -19.00K |
| Total Common Equity | 59.28M | 68.23M | 76.29M | 88.90M | 78.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 59.28M | 68.23M | 76.29M | 88.90M | 78.28M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 59.28M | 68.23M | 76.29M | 88.90M | 78.28M |
|
|
|||||